2019
DOI: 10.1002/pd.5570
|View full text |Cite
|
Sign up to set email alerts
|

Comment on “Mother‐to‐child transmission of hepatitis B virus after amniocentesis: A retrospective matched cohort study”

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
1

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 9 publications
(14 reference statements)
0
0
1
Order By: Relevance
“…The MTCT rate was 2.5% in women who underwent amniocentesis vs 0.5% in patient without invasive procedure and all cases of vertical transmission were in patients HBeAg positive [12]. However, the results should be interpreted with caution, as the reported rate of vertical transmission in this cohort was much lower than previously shown in HBeAg positive patients where the MTCT rate is about 5-10% even in cases without an invasive procedure [13]. Moreover, the study results showed that antiviral therapy a few weeks prior to invasive testing (Tenofovir, Telbivuldine or Lamivudine) seems to reduce MTCT rates in mothers with high viral load (0% vs 14%) [12].…”
Section: Hepatitis B Viruscontrasting
confidence: 56%
“…The MTCT rate was 2.5% in women who underwent amniocentesis vs 0.5% in patient without invasive procedure and all cases of vertical transmission were in patients HBeAg positive [12]. However, the results should be interpreted with caution, as the reported rate of vertical transmission in this cohort was much lower than previously shown in HBeAg positive patients where the MTCT rate is about 5-10% even in cases without an invasive procedure [13]. Moreover, the study results showed that antiviral therapy a few weeks prior to invasive testing (Tenofovir, Telbivuldine or Lamivudine) seems to reduce MTCT rates in mothers with high viral load (0% vs 14%) [12].…”
Section: Hepatitis B Viruscontrasting
confidence: 56%